Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Dolby Family Ventures
AddedFeb 13, 2024
UpdatedJul 3, 2026
Dolby Family Ventures

Dolby Family Ventures

Operating

Dolby Family Ventures LP: A tech venture firm committed to supporting entrepreneurs with finance, strategy, and board development.

Location
San Francisco, CA, US
Founded
2014
Firm
Compare
Portfolio
Employees
Website

Investments

Motif Neurotech
Motif Neurotech

Total Raised

$18.9M

Rounds

2

Series A$18.8MJanuary 2024
Cognitive Space
Cognitive Space

Total Raised

$9.6M

Rounds

6

Seed$4MOctober 2023
Mojo Vision
Mojo Vision

Total Raised

$269.9M

Rounds

9

Series A$43.5MOctober 2023
Series C$22.4MApril 2023
Series B$45MJanuary 2022
Sharrow Marine
Sharrow Marine

Total Raised

$31.1M

Rounds

3

Series Unknown$30MJune 2023
Paradromics
Paradromics

Total Raised

$108.4M

Rounds

9

Series A$50.1MMay 2023
Genemod
Genemod

Total Raised

$8.2M

Rounds

3

Seed$4.5MMay 2023
Therini Bio
Therini Bio

Total Raised

$65.3M

Rounds

4

Series A$36MApril 2023
MooveAI
MooveAI

Total Raised

$3.3M

Rounds

1

Seed$3.3MMarch 2023
Switch Therapeutics
Switch Therapeutics

Total Raised

$52M

Rounds

1

Series A$52MMarch 2023
QurAlis
QurAlis

Total Raised

$135.5M

Rounds

4

Series B$88MMarch 2023
AccuKnox
AccuKnox

Total Raised

$10.6M

Rounds

2

Seed$6MMarch 2023
Cerevance
Cerevance

Total Raised

$142.5M

Rounds

5

Series B$51MFebruary 2023
Atomos Space
Atomos Space
Acquired

Total Raised

$21.9M

Rounds

8

Series A$16.2MJanuary 2023
Cajal Neuroscience
Cajal Neuroscience

Total Raised

$96M

Rounds

2

Series A$96MNovember 2022
Bionaut Labs
Bionaut Labs

Total Raised

$63.2M

Rounds

5

Series B$43.2MNovember 2022
MedCrypt
MedCrypt

Total Raised

$34.4M

Rounds

6

Series B$25MNovember 2022
Canaery
Canaery

Total Raised

$4M

Rounds

5

Seed$4MJuly 2022
MindImmune Therapeutics
MindImmune Therapeutics

Total Raised

$13.7M

Rounds

3

Series A$12.4MJune 2022
Ursa Major
Ursa Major

Total Raised

$271.8M

Rounds

10

Series C$85MDecember 2021
Sepion Technologies
Sepion Technologies

Total Raised

$16M

Rounds

2

Series A$16MNovember 2021
Cala Health
Cala Health

Total Raised

$148.3M

Rounds

4

Series D$77MNovember 2021
H2U Technologies
H2U Technologies

Total Raised

$18M

Rounds

2

Series A$7MOctober 2021
TripleBlind
TripleBlind

Total Raised

$32.2M

Rounds

3

Series A$24MOctober 2021